References automatically added to CGD since 2025-03-21 (possibly not yet curated) |
---|
Reference | Species | Genes Addressed |
---|
Bai W, et al. (2025) Histone deacetylase Hos1 promotes the homeostasis of Candida albicans cell wall and membrane and its specific inhibitor has an antifungal activity in vivo. Microbiol Res 296:128132
| C. albicans | |HOS1 |
Chang TH, et al. (2025) Transkingdom mechanism of MAMP generation by chitotriosidase feeds oligomeric chitin from fungal pathogens and allergens into TLR2-mediated innate immune sensing. Front Immunol 16:1497174
| C. albicans | |SAP2 |SAP6 |
Chiang HS, et al. (2025) MNN45 is involved in Zcf31-mediated cell surface integrity and chitosan susceptibility in Candida albicans. Med Mycol
| C. albicans | |MNN45 |ZCF31 |
Dos Reis Teixeira A, et al. (2025) Brazilian Green Propolis Extract-Loaded Poly(Epsilon-Caprolactone) Nanoparticles Coated with Hyaluronic Acid: Antifungal Activity in a Murine Model of Vulvovaginal Candidiasis. AAPS PharmSciTech 26(3):86
| C. albicans | |C2_09450W_A |C4_02810C_A |
Emidio JJ, et al. (2025) Antifungal Evaluation of Benzoxazole and Benzothiazole Derivatives: An In Vitro and In Silico Study. Chem Biodivers :e202403459
| C. albicans | |HSP90 |
Min K and Park A (2025) Shape-Shifting Mechanisms: Integrative Multi-Omics Insights Into Candida albicans Morphogenesis. Mycobiology 53(2):250-257
| C. albicans | |CDC28 |
Ottaviano E, et al. (2025) Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content. Microbiol Spectr :e0298724
| C. albicans | |ERG2 |
Shirley DJ, et al. (2025) Chemoproteomic Profiling of C. albicans for Characterization of Antifungal Kinase Inhibitors. J Med Chem
| C. albicans | |C2_08270C_A |HOG1 |HRR25 |YCK2 |
Tosiano MA, et al. (2025) Roles of P-body factors in Candida albicans filamentation and stress response. PLoS Genet 21(3):e1011632
| C. albicans | |DHH1 |EDC3 |
Zaman R, et al. (2025) Role of ERG3 mutation and expression in azole resistant Candida albicans isolated from vulvovaginal candidiasis patients. Pak J Med Sci 41(3):861-866
| C. albicans | |ERG3 |
Zhao M, et al. (2025) Functional analysis of Candida albicans Cdr1 through homologous and heterologous expression studies. FEMS Yeast Res
| C. albicans | |CDR1 |
Pfaller MA, et al. (2012) Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen. Curr Fungal Infect Rep 6(3):154-164
| C. glabrata | |PDR1 |